Search research articles
Contact Us
Filters
Showing results (121-130 of 199) with videos related to
Page
of 20
Sort By:
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
The Journal of Clinical Investigation
|
December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Blood Advances
|
December 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis
Peter A Riedell, Connor B Grady, Loretta J Nastoupil, et al.
Leukemia & Lymphoma
|
June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation
Craig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma
|
March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
Molly E Graveno, Alison Carulli, Craig W Freyer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
Michael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Autophagy
|
July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma
Dan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
Donald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Science Translational Medicine
|
September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 199) with videos related to
Sort By:
Page
of 20
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
The Journal of Clinical Investigation
|
December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Blood Advances
|
December 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis
Peter A Riedell, Connor B Grady, Loretta J Nastoupil, et al.
Leukemia & Lymphoma
|
June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation
Craig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma
|
March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
Molly E Graveno, Alison Carulli, Craig W Freyer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
Michael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Autophagy
|
July 4, 2014
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma
Dan T Vogl, Edward A Stadtmauer, Kay-See Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia
Donald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Science Translational Medicine
|
September 4, 2015
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L Porter, Wei-Ting Hwang, Noelle V Frey, et al.
Page
of 20